Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2021

01-12-2021 | Prostate Cancer | Review

Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta‐analysis

Authors: Xinhao Niu, Zhe Zhu, Juan Bao

Published in: Cancer Cell International | Issue 1/2021

Login to get access

Abstract

Background

Controlling Nutritional Status (CONUT) score is a novel nutrition-based biomarker that has been reported for predicting survival in various cancers. However, the relationship between CONUT score and prognosis of urological cancers remains unclear. Hence, we performed this meta-analysis to evaluate the prognostic significance of CONUT score for patients with urological cancers.

Methods

PubMed, Embase, the Cochrane Library and National Knowledge Infrastructure (CNKI) were systematically searched up to October 2020. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to evaluate the association of CONUT score with overall survival (OS), cancer-specific survival (CSS) and recurrence/disease/progress-free survival (RFS/DFS/PFS) in urological cancers.

Results

A total of 12 articles with 13 studies were included in the analysis. Pooled results indicated that increased CONUT score predicted poor OS (HR: 1.78, 95% CI 1.51–2.09, p < 0.001), CSS (HR: 2.14, 95% CI 1.55–2.97, p < 0.001) and RFS/DFS/PFS (HR: 1.57, 95% CI 1.35–1.84, p < 0.001). Subgroup analysis by cancer type revealed that high CONUT score associated with worse OS in renal cell carcinoma (RCC) and urothelial cancer (UC) (HR: 3.05, 95% CI 2.07–4.50, p < 0.001; HR: 1.58, 95% CI 1.32–1.89, p < 0.001). Similar results could be found in CSS (RCC HR: 2.67, 95% CI 1.87–3.81, p < 0.011; UC HR: 1.68, 95% CI 1.09–2.59, p = 0.011) and in RFS/DFS/PFS (RCC HR: 1.96, 95% CI 1.44–2.66, p < 0.001; UC HR: 1.42, 95% CI 1.18–1.71, p < 0.001).

Conclusions

These results illustrated that the high CONUT score may predict worse survival for patients suffering from urological cancers. Therefore, the CONUT score may represent an effective prognostic indicator in urological cancers.
Literature
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.PubMed
2.
3.
4.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefPubMed
5.
Jerónimo C, Henrique R. Epigenetic biomarkers in urological tumors: A systematic review. Cancer Lett. 2014;342:264–74.CrossRefPubMed
6.
Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol. 2018;73:111–22.CrossRefPubMed
7.
Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical Value of Nutritional Status in Cancer: What is its Impact and how it Affects Disease Progression and Prognosis? Nutr Cancer. 2017;69:1151–76.CrossRefPubMed
8.
Qi F, Zhou X, Wang Y, et al. Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis. Cancer Cell Int. 2018;18:207.CrossRefPubMedPubMedCentral
9.
Qi F, Xu Y, Zheng Y, Li X, Gao Y. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis. Ann Transl Med. 2019;7:531.CrossRefPubMedPubMedCentral
10.
Mori K, Miura N, Mostafaei H, et al. Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis. International Journal of Clinical Oncology. 2020;25:1459–74.CrossRefPubMedPubMedCentral
11.
Liu J, Wang F, Li S, Huang W, Jia Y, Wei C. The prognostic significance of preoperative serum albumin in urothelial carcinoma: a systematic review and meta-analysis. Biosci Rep. 2018;38:12.
12.
Takagi K, Domagala P, Polak WG, Buettner S, Wijnhoven BPL, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis. BMC Surg. 2019;19:129.CrossRefPubMedPubMedCentral
13.
Takagi K, Domagala P, Polak WG, Buettner S, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2019;19:211.CrossRefPubMedPubMedCentral
14.
Takagi K, Buettner S, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients with colorectal cancer: A systematic review and meta-analysis. Int J Surg. 2020;78:91–6.CrossRefPubMed
15.
Miyake M, Morizawa Y, Hori S, et al. Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy. Oncology. 2017;93:259–69.CrossRefPubMed
16.
Takemura K, Yuasa T, Fujiwara R, et al. Prognostic Significance of the controlling nutritional status (CONUT) score in patients with advanced renal cell carcinoma treated with nivolumab after failure of prior tyrosine kinase inhibitors. J Urol. 2020;204:1166–72.CrossRefPubMed
17.
Bao Z, Li Y, Guan B, et al. High preoperative controlling nutritional status score predicts a poor prognosis in patients with localized upper tract urothelial cancer: a propensity score matching study in a large Chinese center. Cancer Manag Res. 2020;12:323–35.CrossRefPubMedPubMedCentral
18.
Song H, Xu B, Luo C, et al. The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study. Cancer Manag Res. 2019;11:7567–75.CrossRefPubMedPubMedCentral
19.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.CrossRefPubMedPubMedCentral
20.
Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRefPubMed
21.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed
22.
Guo K, Wang T, Yuan S, et al. Applicative value of controlling nutritional status to predict survival after cystectomy for patients with bladder cancer. J Mod Urol. 2017;22:925–9.
23.
Zhang W, Wu Y, Zhang Z, et al. Controlling Nutritional Status score: a new prognostic indicator for patients with oligometastatic prostate cancer. Curr Probl Cancer. 2019;43:461–70.CrossRefPubMed
24.
Elghiaty A, Kim J, Jang WS, et al. Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. J Cancer Res Clin Oncol. 2019;145:957–65.CrossRefPubMed
25.
Ishihara H, Kondo T, Yoshida K, et al. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. Urol Oncol. 2017;35:539.e9-.e16.
26.
Kang HW, Seo SP, Kim WT, et al. Prognostic impact of nutritional status assessed by the controlling nutritional status (CONUT) score in patients with surgically treated renal cell carcinoma. Nutr Cancer. 2018;70:886–94.CrossRefPubMed
27.
Zheng Y, Bao L, Wang W, Wang Q, Pan Y, Gao X. Prognostic impact of the controlling nutritional status score following curative nephrectomy for patients with renal cell carcinoma. Medicine. 2018;97:e13409.CrossRefPubMedPubMedCentral
28.
Suzuki H, Ito M, Takemura K, et al. Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients. Urol Oncol. 2020;38:11–7.CrossRef
29.
Xu H, Tan P, Jin X, et al. Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma. Cancer Med. 2018;7:6112–23.CrossRefPubMedPubMedCentral
30.
Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74–84.CrossRefPubMed
31.
Chamie K, Litwin MS, Bassett JC, et al. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013;119:3219–27.CrossRefPubMed
32.
Fu XL, Duan W, Su CY, et al. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunol Immunother. 2017;66:1597–608.CrossRefPubMed
33.
Chimento A, Casaburi I, Avena P, et al. Cholesterol and its metabolites in tumor growth: therapeutic potential of statins in cancer treatment. Front Endocrinol (Lausanne). 2018;9:807.CrossRef
34.
Resnik N, Sepcic K, Plemenitas A, Windoffer R, Leube R, Veranic P. Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J Biol Chem. 2011;286:1499–507.CrossRefPubMed
35.
Minami T, Minami T, Shimizu N, et al. Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24 + patients with renal cell carcinoma. J Immunother. 2015;38:285–91.CrossRefPubMed
36.
Mehrazin R, Uzzo RG, Kutikov A, et al. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol. 2015;33:388.e19-25.PubMed
Metadata
Title
Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta‐analysis
Authors
Xinhao Niu
Zhe Zhu
Juan Bao
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2021
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-021-01813-2

Other articles of this Issue 1/2021

Cancer Cell International 1/2021 Go to the issue

Primary research

Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

Review

Roles of ferroptosis in urologic malignancies

Primary research

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma

Review

Circular RNAs and their role in renal cell carcinoma: a current perspective

Primary research

Identification of potential plasma biomarkers in early-stage nasopharyngeal carcinoma-derived exosomes based on RNA sequencing

Review

Using dynamic cell communication improves treatment strategies of breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits